Рак желчного пузыря: эпидемиология, факторы риска
Инна Викторовна Друк,
Галина Ивановна Нечаева,
Елена Александровна Лялюкова,
Елена Владимировна Семенова https://doi.org/10.31146/1682-8658-ecg-205-9-153-160
Аннотация
Рак желчного пузыря (РЖП) - редкое, но высоко злокачественное новообразование. Большинство случаев выявляется случайно у пациентов, проходящих обследование по поводу желчнокаменной болезни. Считается, что неблагоприятный прогноз, связанный с РЖП, связан с поздней стадией при постановке диагноза, что обусловлено как анатомическим положением желчного пузыря, так и нечеткостью и неспецифичностью симптомов, что повышает актуальность изучения и освещения данной тематики. Хотя имеющиеся данные подтверждают снижение общей заболеваемости РЖП за последние 30 лет, заболеваемость может увеличиваться у молодых людей. В глобальном масштабе бремя рака желчного пузыря и других видов рака желчевыводящих путей возросло за последние 30 лет. Для РЖП было выявлено несколько факторов риска, многие из которых имеют общие характеристики хронического воспаления желчного пузыря. В статье рассматриваются основные факторы риска и заболевания, предшествующие развитию рака. Цель обзора - представить анализ современных литературных данных об эпидемиологии настоящего заболевания и факторах риска.
Об авторах
Инна Викторовна Друк
ФГБОУ ВО «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Галина Ивановна Нечаева
ФГБОУ ВО «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Елена Александровна Лялюкова
ФГБОУ ВО «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Елена Владимировна Семенова
ФГБОУ ВО «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Список литературы
1. Yamaguchi K., Chijiiwa K., Ichimiya H., et al. Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg. 1996; 131:981. doi:10.1001/archsurg.1996.01430210079015
2. A prospective analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club. N Engl J Med. 1991; 324:1073. doi:10.1056/NEJM199104183241601
3. Strom B.L., Soloway R. D., Rios-Dalenz J.L., et al. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer. 1995; 76:1747
4. Randi G., Franceschi S., La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors.Int J Cancer. 2006; 118:1591. doi: 10.1002/ijc.21683
5. Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Available at: https://gco.iarc.fr/ Accessed: 05 March 2022.
6. Lazcano-Ponce E.C., Miquel J. F., Muñoz N., et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001; 51:349. doi:10.3322/canjclin.51.6.349
7. Wistuba I.I., Gazdar A. F. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004; 4:695. doi:10.1038/nrc1429
8. Miquel J.F., Covarrubias C., Villaroel L., et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 1998; 115:937. doi: 10.1016/s0016-5085(98)70266
9. Serra I., Calvo A., Báez S., et al. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer. 1996; 78:1515. PMID: 8839560
10. Randi G., Malvezzi M., Levi F., et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009; 20:146. doi: 10.1093/annonc/mdn533. Epub 2008 Jul 29.
11. Rahman R., Simoes E. J., Schmaltz C., et al. Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study. Cancer Med. 2017; 6:874. doi: 10.1002/cam4.1044
12. Diehl A. K. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst. 1980; 65:1209. PMID: 6933267.
13. Kiran R.P., Pokala N., Dudrick S. J. Incidence pattern and survival for gallbladder cancer over three decades - an analysis of 10301 patients. Ann Surg Oncol. 2007; 14:827. doi: 10.1245/s10434-006-9224-4
14. Yang J.D., Kim B., Sanderson S. O., et al. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. Am J Gastroenterol. 2012; 107:1256. doi: 10.1038/ajg.2012.173
15. Ouyang G., Liu Q., Wu Y., et al. The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study 2017. Cancer. 2021; 127:2238. doi: 10.1002/cncr.33476
16. Duffy A., Capanu M., Abou-Alfa G.K., et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008; 98:485. doi: 10.1002/jso.21141
17. Konstantinidis I.T., Deshpande V., Genevay M., et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg. 2009; 144:441. doi: 10.1001/archsurg.2009.46
18. Scott T.E., Carroll M., Cogliano F. D., et al. A case-control assessment of risk factors for gallbladder carcinoma. Dig Dis Sci. 1999; 44:1619. doi: 10.1023/a:1026675329644
19. Caygill C.P., Hill M. J., Braddick M., Sharp J. C. Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet. 1994; 343:83. doi: 10.1016/s0140-6736(94)90816-8
20. Hsing A.W., Gao Y. T., Han T. Q., et al. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer. 2007; 97:1577. doi: 10.1038/sj.bjc.6604047
21. Maringhini A., Moreau J. A., Melton L. J. 3rd., et al. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med. 1987; 107:30. doi: 10.7326/0003-4819-107-1-30
22. Paraskevopoulos J.A., Dennison A. R., Ross B., Johnson A. G. Primary carcinoma of the gallbladder: a 10-year experience. Ann R Coll Surg Engl. 1992; 74:222. PMCID: PMC2497579.
23. Zatonski W.A., Lowenfels A. B., Boyle P., et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst. 1997; 89:1132. doi: 10.1093/jnci/89.15.1132
24. Ghadirian P., Simard A., Baillargeon J. A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada. Rev Epidemiol Sante Publique. 1993; 41:107. PMID: 8493388.
25. Chow W.H., Johansen C., Gridley G., et al. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer. 1999; 79:640. doi: 10.1038/sj.bjc.6690101
26. Valle J.W., Kelley R. K., Nervi B., et al. Biliary tract cancer. Lancet. 2021; 397:428. doi: 10.1016/S0140-6736(21)00153-7
27. Muszynska C., Lundgren L., Lindell G., et al. Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease: Results from a population-based gallstone surgery registry. Surgery. 2017; 162:256. doi: 10.1016/j.surg.2017.02.009
28. Hsing A.W., Bai Y., Andreotti G., et al. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.Int J Cancer. 2007; 121:832. doi: 10.1002/ijc.22756
29. Misra S., Chaturvedi A., Misra N. C., Sharma I. D. Carcinoma of the gallbladder. Lancet Oncol. 2003; 4:167. doi: 10.1016/s1470-2045(03)01021-0
30. Glenn F., Hays D. M. The scope of radical surgery in the treatment of malignant tumors of the extrahepatic biliary tract. Surg Gynecol Obstet. 1954; 99:529. PMID: 13205425.
31. Wistuba I.I., Miquel J. F., Gazdar A. F., Albores-Saavedra J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol. 1999; 30:21. doi: 10.1016/s0046-8177(99)90295-2
32. Szpakowski J.L., Tucker L. Y. Outcomes of Gallbladder Polyps and Their Association With Gallbladder Cancer in a 20-Year Cohort. JAMA Netw Open. 2020; 3: e205143. doi: 10.1001/jamanetworkopen.2020.5143
33. Okamoto M., Okamoto H., Kitahara F., et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am J Gastroenterol. 1999; 94:446. doi: 10.1111/j.1572-0241.1999.875_d.x
34. Said K., Glaumann H., Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol. 2008; 48:598. doi: 10.1016/j.jhep.2007.11.019
35. Chapman R., Fevery J., Kalloo A., et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51:660. doi: 10.1002/hep.23294
36. Hundal R., Shaffer E. A. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014; 6:99. doi: 10.2147/CLEP.S37357
37. Dutta U., Garg P. K., Kumar R., Tandon R. K. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol. 2000; 95:784. doi: 10.1111/j.1572-0241.2000.01860.x
38. Shukla V.K., Singh H., Pandey M., et al. Carcinoma of the gallbladder - is it a sequel of typhoid? Dig Dis Sci. 2000; 45:900. doi: 10.1023/a:1005564822630
39. Nath G., Singh H., Shukla V. K. Chronic typhoid carriage and carcinoma of the gallbladder. Eur J Cancer Prev. 1997; 6:557. doi: 10.1097/00008469-199712000-00011
40. Nagaraja V., Eslick G. D. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther. 2014; 39:745. doi: 10.1111/apt.12655
41. Kobayashi T., Harada K., Miwa K., Nakanuma Y. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci. 2005; 50:862. doi: 10.1007/s10620-005-2654-1
42. Murata H., Tsuji S., Tsujii M., et al. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther. 2004; 20 Suppl 1:90. doi: 10.1111/j.1365-2036.2004.01972.x
43. Fukuda K., Kuroki T., Tajima Y., et al.Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis. 2002; 23:1927. doi: 10.1093/carcin/23.11.1927
44. Matsukura N., Yokomuro S., Yamada S., et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res. 2002; 93:842. doi: 10.1111/j.1349-7006.2002.tb01327.x
45. Metz D. C. Helicobacter colonization of the biliary tree: commensal, pathogen, or spurious finding? Am J Gastroenterol. 1998; 93:1996. doi: 10.1111/j.1572-0241.1998.01996.x
46. Voyles C.R., Smadja C., Shands W. C., Blumgart L. H. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg. 1983; 118:986. doi: 10.1001/archsurg.1983.01390080088022
47. Song H.K., Kim M. H., Myung S. J., et al. Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone. Korean J Intern Med. 1999; 14:1. doi: 10.3904/kjim.1999.14.2.1
48. Chijiiwa K., Kimura H., Tanaka M. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst.Int Surg. 1995; 80:61. PMID: 7657495.
49. Hasumi A., Matsui H., Sugioka A., et al. Precancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction: reappraisal of nationwide survey in Japan. J Hepatobiliary Pancreat Surg. 2000; 7:551. doi: 10.1007/s005340070003
50. Hu B., Gong B., Zhou D. Y. Association of anomalous pancreaticobiliary ductal junction with gallbladder carcinoma in Chinese patients: an ERCP study. Gastrointest Endosc. 2003; 57:541. doi: 10.1067/mge.2003.136
51. Elnemr A., Ohta T., Kayahara M., et al. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer. Hepatogastroenterology. 2001; 48:382. PMID: 11379314.
52. Sugiyama M., Abe N., Tokuhara M., et al. Pancreatic carcinoma associated with anomalous pancreaticobiliary junction. Hepatogastroenterology. 2001; 48:1767. PMID: 11813620.
53. Sugiyama M., Atomi Y. Anomalous pancreaticobiliary junction without congenital choledochal cyst. Br J Surg. 1998; 85:911. doi: 10.1046/j.1365-2168.1998.00744.x
54. Funabiki T., Matsubara T., Ochiai M., et al. Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation. Keio J Med. 1997; 46:169. doi: 10.2302/kjm.46.169
55. Brodén G., Bengtsson L. Biliary carcinoma associated with methyldopa therapy. Acta Chir Scand Suppl. 1980; 500:7. PMID: 6939199.
56. Littlewood E.R., Barrison G., et al. Cholangiocarcinoma and oral contraceptives. Lancet. 1980 Feb 9;1(8163):310-1. doi: 10.1016/s0140-6736(80)90804-1
57. Lowenfels A.B., Norman J. Isoniazid and bile duct cancer. JAMA. 1978; 240:434. doi:10.1001/jama.1978.0329005002400
58. Milne R., Vessey M. The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumours. Contraception. 1991; 43:667. doi: 10.1016/0010-7824(91)90009-5
59. Combined oral contraceptives and gallbladder cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.Int J Epidemiol. 1989; 18:309. doi: 10.1093/ije/18.2.309
60. Pandey M., Shukla V. K. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev. 2003; 12:269. doi: 10.1097/00008469-200308000-00005
61. Darby S.C., Whitley E., Howe G. R., et al. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Cancer Inst. 1995; 87:378. doi: 10.1093/jnci/87.5.378
62. Grainge M.J., West J., Solaymani-Dodaran M., et al. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer. 2009; 100:178. doi: 10.1038/sj.bjc.6604765
63. Yagyu K., Kikuchi S., Obata Y., et al. Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan.Int J Cancer. 2008; 122:924. doi: 10.1002/ijc.23159
64. Koshiol J., Gao Y. T., Dean M., et al. Association of Aflatoxin and Gallbladder Cancer. Gastroenterology. 2017; 153:488. doi: 10.1053/j.gastro.2017.04.005
65. Engeland A., Tretli S., Austad G., Bjørge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control. 2005; 16:987. doi: 10.1007/s10552-005-3638-3
66. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348:1625. doi: 10.1056/NEJMoa021423
67. Hsing A.W., Sakoda L. C., Rashid A., et al. Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer. 2008; 99:811. doi: 10.1038/sj.bjc.6604616
68. Lauby-Secretan B., Scoccianti C., Loomis D., et al. Body Fatness and Cancer - Viewpoint of the IARC Working Group. N Engl J Med. 2016; 375:794. doi: 10.1056/NEJMsr1606602
69. Shebl F.M., Andreotti G., Rashid A., et al. Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer. 2010; 103:115. doi: 10.1038/sj.bjc.6605706
70. Welzel T.M., Graubard B. I., El-Serag H.B., et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007; 5:1221. doi: 10.1371/journal.pone.0186643
71. Larsson S.C., Giovannucci E. L., Wolk A. Sweetened Beverage Consumption and Risk of Biliary Tract and Gallbladder Cancer in a Prospective Study. J Natl Cancer Inst. 2016; 108. doi:10.1093/jnci/djw125
72. Berk R.N., Armbuster T. G., Saltzstein S. L. Carcinoma in the porcelain gallbladder. Radiology. 1973; 106:29. doi:10.1148/106.1.29
73. Shimizu M., Miura J., Tanaka T., et al. Porcelain gallbladder: relation between its type by ultrasound and incidence of cancer. J Clin Gastroenterol. 1989; 11:471. PMID: 2668401.
74. Kane R.A., Jacobs R., Katz J., Costello P. Porcelain gallbladder: ultrasound and CT appearance. Radiology. 1984; 152:137. doi: 10.1148/radiology.152.1.6729103
75. CORNELL C.M., CLARKE R. Vicarious calcification involving the gallbladder. Ann Surg. 1959; 149:267. doi: 10.1097/00000658-195902000-00013
76. Khan Z.S., Livingston E. H., Huerta S. Reassessing the need for prophylactic surgery in patients with porcelain gallbladder: case series and systematic review of the literature. Arch Surg. 2011; 146:1143. doi: 10.1001/archsurg.2011.257
77. Polk H. C. Jr. Carcinoma and the calcified gall bladder. Gastroenterology. 1966; 50:582. PMID: 4286335.
78. Stephen A.E., Berger D. L. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery. 2001; 129:699. doi: 10.1067/msy.2001.113888
79. Etala E. [Gallbladder cancer]. Prensa Med Argent. 1967; 54:1479. PMID: 5597119.
80. Ashur H., Siegal B., Oland Y., Adam Y. G. Calcified ballbladder (porcelain gallbladder). Arch Surg. 1978; 113:594. doi: 10.1001/archsurg.1978.01370170056010
81. Søreide K., Søreide J. A. Bile duct cyst as precursor to biliary tract cancer. Ann Surg Oncol. 2007; 14:1200. doi: 10.1245/s10434-006-9294-3
82. Lee S.E., Jang J. Y., Lee Y. J., et al. Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg. 2011; 146:1178. doi: 10.1001/archsurg.2011.243
83. de Kleine R. H., Schreuder A. M., Ten Hove A., et al. Choledochal malformations in adults in the Netherlands: Results from a nationwide retrospective cohort study. Liver Int. 2020; 40:2469. doi: 10.1111/liv.14568
84. Voyles C.R., Smadja C., Shands W. C., Blumgart L. H. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg. 1983; 118:986. doi: 10.1001/archsurg.1983.01390080088022
85. Todani T., Watanabe Y., Toki A., Urushihara N. Carcinoma related to choledochal cysts with internal drainage operations. Surg Gynecol Obstet. 1987; 164:61. PMID: 3026058.
86. Kobayashi S., Asano T., Yamasaki M., et al. Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction. Surgery. 1999; 126:939. doi: 10.1016/s0039-6060(99)70036-x
87. Watanabe Y., Toki A., Todani T. Bile duct cancer developed after cyst excision for choledochal cyst. J Hepatobiliary Pancreat Surg. 1999; 6:207. doi: 10.1007/s005340050108
88. Sastry A.V., Abbadessa B., Wayne M. G., et al. What is the incidence of biliary carcinoma in choledochal cysts, when do they develop, and how should it affect management? World J Surg. 2015; 39:487. doi: 10.1007/s00268-014-2831-5
89. Todani T., Tabuchi K., Watanabe Y., Kobayashi T. Carcinoma arising in the wall of congenital bile duct cysts. Cancer. 1979; 44:1134. Doi:10.1002/1097-0142(197909)44:3<1134: AID-CNCR2820440350>3.0.CO;2-T
90. Lobeck I.N., Dupree P., Falcone R. A. Jr., et al. The presentation and management of choledochocele (type III choledochal cyst): A 40-year systematic review of the literature. J Pediatr Surg. 2017; 52:644. doi: 10.1016/j.jpedsurg.2016.10.008
91. Ohtsuka T., Inoue K., Ohuchida J., et al. Carcinoma arising in choledochocele. Endoscopy. 2001; 33:614. doi: 10.1055/s-2001-15324
92. Dayton M.T., Longmire W. P. Jr., Tompkins R. K. Caroli’s Disease: a premalignant condition? Am J Surg. 1983; 145:41. doi: 10.1016/0002-9610(83)90164-2
93. Singham J., Yoshida E. M., Scudamore C. H. Choledochal cysts: part 1 of 3: classification and pathogenesis. Can J Surg. 2009; 52:434. PMID: 19865581.
94. Ragot E., Mabrut J. Y., Ouaïssi M., et al. Pancreaticobiliary Maljunctions in European Patients with Bile Duct Cysts: Results of the Multicenter Study of the French Surgical Association (AFC). World J Surg. 2017; 41:538. doi: 10.1007/s00268-016-3684-x
95. Song H.K., Kim M. H., Myung S. J., et al. Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone. Korean J Intern Med. 1999; 14:1. doi: 10.3904/kjim.1999.14.2.1
96. Funabiki T., Matsubara T., Ochiai M., et al. Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation. Keio J Med. 1997; 46:169. doi: 10.2302/kjm.46.169
97. Hidaka E., Yanagisawa A., Seki M., et al. High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater. Cancer Res. 2000; 60:522. PMID: 10676628.
98. UpToDate Galbladder Cancer. Accessed: 31.03.2022.
Рецензия
Для цитирования:
Друк И.В., Нечаева Г.И., Лялюкова Е.А., Семенова Е.В. Рак желчного пузыря: эпидемиология, факторы риска. Экспериментальная и клиническая гастроэнтерология. 2022;(9):153-160. https://doi.org/10.31146/1682-8658-ecg-205-9-153-160
For citation:
Druk I.V., Nechaeva G.I., Lyalyukova E.A., Semenova E.V. Gallbladder cancer: epidemiology, risk factors. Experimental and Clinical Gastroenterology. 2022;(9):153-160. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-205-9-153-160
Просмотров:
391
Послать статью по эл. почте 